164 related articles for article (PubMed ID: 18758476)
21. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
Dumortier A; Jeannet R; Kirstetter P; Kleinmann E; Sellars M; dos Santos NR; Thibault C; Barths J; Ghysdael J; Punt JA; Kastner P; Chan S
Mol Cell Biol; 2006 Jan; 26(1):209-20. PubMed ID: 16354692
[TBL] [Abstract][Full Text] [Related]
22. Notch tumor suppressor function.
Dotto GP
Oncogene; 2008 Sep; 27(38):5115-23. PubMed ID: 18758480
[TBL] [Abstract][Full Text] [Related]
23. [Ubiquitylation-mediated regulation of notch signaling].
Tsunematsu R
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1282-6. PubMed ID: 16922388
[No Abstract] [Full Text] [Related]
24. [Notch activation during T-cell leukemogenesis in Ikaros-deficient mice].
Kastner P; Chan S
Med Sci (Paris); 2006; 22(8-9):708-10. PubMed ID: 16962043
[No Abstract] [Full Text] [Related]
25. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
[TBL] [Abstract][Full Text] [Related]
26. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.
Aster JC; Blacklow SC; Pear WS
J Pathol; 2011 Jan; 223(2):262-73. PubMed ID: 20967796
[TBL] [Abstract][Full Text] [Related]
27. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture.
Chiaramonte R; Calzavara E; Balordi F; Sabbadini M; Capello D; Gaidano G; Serra A; Comi P; Sherbet GV
J Cell Biochem; 2003 Feb; 88(3):569-77. PubMed ID: 12532332
[TBL] [Abstract][Full Text] [Related]
29. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
Feng Z; Hu W; de Stanchina E; Teresky AK; Jin S; Lowe S; Levine AJ
Cancer Res; 2007 Apr; 67(7):3043-53. PubMed ID: 17409411
[TBL] [Abstract][Full Text] [Related]
30. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
[TBL] [Abstract][Full Text] [Related]
31. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line.
Kathrein KL; Lorenz R; Innes AM; Griffiths E; Winandy S
Mol Cell Biol; 2005 Mar; 25(5):1645-54. PubMed ID: 15713624
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.
Lobry C; Oh P; Aifantis I
J Exp Med; 2011 Sep; 208(10):1931-5. PubMed ID: 21948802
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
[TBL] [Abstract][Full Text] [Related]
34. Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis.
Beverly LJ; Capobianco AJ
Cancer Cell; 2003 Jun; 3(6):551-64. PubMed ID: 12842084
[TBL] [Abstract][Full Text] [Related]
35. p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies.
Wickremasinghe RG; Prentice AG; Steele AJ
Leukemia; 2011 Sep; 25(9):1400-7. PubMed ID: 21566651
[TBL] [Abstract][Full Text] [Related]
36. Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing.
Bellavia D; Mecarozzi M; Campese AF; Grazioli P; Talora C; Frati L; Gulino A; Screpanti I
EMBO J; 2007 Mar; 26(6):1670-80. PubMed ID: 17332745
[TBL] [Abstract][Full Text] [Related]
37. Notch signaling in the immune system.
Radtke F; Fasnacht N; Macdonald HR
Immunity; 2010 Jan; 32(1):14-27. PubMed ID: 20152168
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling in T-cell acute lymphoblastic leukemia.
Weng AP; Lau A
Future Oncol; 2005 Aug; 1(4):511-9. PubMed ID: 16556027
[TBL] [Abstract][Full Text] [Related]
39. Notch signaling: switching an oncogene to a tumor suppressor.
Lobry C; Oh P; Mansour MR; Look AT; Aifantis I
Blood; 2014 Apr; 123(16):2451-9. PubMed ID: 24608975
[TBL] [Abstract][Full Text] [Related]
40. Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications.
Cardoso BA; Gírio A; Henriques C; Martins LR; Santos C; Silva A; Barata JT
Braz J Med Biol Res; 2008 May; 41(5):344-50. PubMed ID: 18488097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
